Bradley C. Leibovich

Mayo Clinic in Arizona, Mayo Clinic

Papers

8

Total Citations

545

H-Index

6

About

Bradley C. Leibovich is a leading urologic oncologist whose research has fundamentally shaped the surgical management of kidney cancer. His work centers on optimizing patient outcomes through refined surgical techniques and evidence-based decision-making, particularly for renal cell carcinoma. Leibovich is best known for developing the Mayo Adhesive Probability (MAP) score, a groundbreaking imaging-based system that predicts adherent perinephric fat before partial nephrectomy. This tool, detailed in his highly cited 2014 paper (294 citations), helps surgeons anticipate difficult dissections and reduce complications. He has also been a key voice in the debate over treatment for small renal masses, with his 2018 study (39 citations) demonstrating that the diffusion of robotic surgery was associated with increased overtreatment—a critical finding for clinical practice. His 2012 systematic review and meta-analysis (70 citations) provided comparative effectiveness data on partial versus radical nephrectomy, influencing guidelines worldwide. Beyond kidney cancer, Leibovich advanced minimally invasive techniques, including robot-assisted retroperitoneal lymph node dissection (110 citations). His work consistently bridges surgical innovation with rigorous outcomes research, making him a pivotal figure in modern urologic oncology.

Research Focus

Key Achievements

6
H-Index
8
Papers
545
Total Citations
68
Avg Citations/Paper
🏆 Most Cited Paper
Mayo Adhesive Probability Score: An Accurate Image-based Scoring System to Predict Adherent Perinephric Fat in Partial Nephrectomy
294 citations · 2014
📈 Most Prolific Year: 2014 (2 Papers)
🤝 Key Collaborators: 39
🏛 Institutions: Mayo Clinic in Arizona, Mayo Clinic

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago